221 related articles for article (PubMed ID: 3782473)
1. Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity.
Perez HD; Chenoweth DE; Goldstein IM
J Clin Invest; 1986 Dec; 78(6):1589-95. PubMed ID: 3782473
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of the chemotactic activity of human C5a des Arg by an anionic polypeptide ("cochemotaxin") in normal serum and plasma.
Perez HD; Goldstein IM; Webster RO; Henson PM
J Immunol; 1981 Feb; 126(2):800-4. PubMed ID: 7451994
[TBL] [Abstract][Full Text] [Related]
3. Identification of the C5a des Arg cochemotaxin. Homology with vitamin D-binding protein (group-specific component globulin).
Perez HD; Kelly E; Chenoweth D; Elfman F
J Clin Invest; 1988 Jul; 82(1):360-3. PubMed ID: 3392212
[TBL] [Abstract][Full Text] [Related]
4. Human C5a and C5a des Arg exhibit chemotactic activity for fibroblasts.
Senior RM; Griffin GL; Perez HD; Webster RO
J Immunol; 1988 Nov; 141(10):3570-4. PubMed ID: 3183381
[TBL] [Abstract][Full Text] [Related]
5. Human monocyte adherence: a primary effect of chemotactic factors on the monocyte to stimulate adherence to human endothelium.
Doherty DE; Haslett C; Tonnesen MG; Henson PM
J Immunol; 1987 Mar; 138(6):1762-71. PubMed ID: 3819394
[TBL] [Abstract][Full Text] [Related]
6. Specific inhibitor of complement (C5)-derived chemotactic activity in systemic lupus erythematosus related antigenically to the Bb fragment of human factor B.
Perez HD; Hooper C; Volanakis J; Ueda A
J Immunol; 1987 Jul; 139(2):484-9. PubMed ID: 3648093
[TBL] [Abstract][Full Text] [Related]
7. Chemotactic peptides modulate adherence of human polymorphonuclear leukocytes to monolayers of cultured endothelial cells.
Charo IF; Yuen C; Perez HD; Goldstein IM
J Immunol; 1986 May; 136(9):3412-9. PubMed ID: 3514759
[TBL] [Abstract][Full Text] [Related]
8. Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg.
Marder SR; Chenoweth DE; Goldstein IM; Perez HD
J Immunol; 1985 May; 134(5):3325-31. PubMed ID: 3884709
[TBL] [Abstract][Full Text] [Related]
9. Various authentic chemoattractants mediating leukocyte adherence inhibition.
Thomson DM
J Natl Cancer Inst; 1984 Sep; 73(3):595-605. PubMed ID: 6088878
[TBL] [Abstract][Full Text] [Related]
10. Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg.
Kew RR; Webster RO
J Clin Invest; 1988 Jul; 82(1):364-9. PubMed ID: 3392213
[TBL] [Abstract][Full Text] [Related]
11. Polymorphonuclear leukocyte chemotaxis in systemic lupus erythematosus.
Perez HD; Goldstein IM
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():53-8. PubMed ID: 3612652
[TBL] [Abstract][Full Text] [Related]
12. Identification of the C5a des Arg cochemotaxin.
Perez HD; Kelly E; Chenoweth D; Elfman F
Trans Assoc Am Physicians; 1988; 101():242-9. PubMed ID: 3077730
[No Abstract] [Full Text] [Related]
13. Gc globulin (vitamin D-binding protein) increases binding of low concentrations of C5a des Arg to human polymorphonuclear leukocytes: an explanation for its cochemotaxin activity.
Perez HD
Inflammation; 1994 Apr; 18(2):215-20. PubMed ID: 8070905
[TBL] [Abstract][Full Text] [Related]
14. Quantification of chemotactic peptides (C5a anaphylatoxin and IL-8) in psoriatic lesional skin.
Takematsu H; Tagami H
Arch Dermatol; 1993 Jan; 129(1):74-80. PubMed ID: 8420495
[TBL] [Abstract][Full Text] [Related]
15. The in vivo effect of leukotriene B4 on polymorphonuclear leukocytes and the microcirculation. Comparison with activated complement (C5a des Arg) and enhancement by prostaglandin E2.
Movat HZ; Rettl C; Burrowes CE; Johnston MG
Am J Pathol; 1984 May; 115(2):233-44. PubMed ID: 6326579
[TBL] [Abstract][Full Text] [Related]
16. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
Gerard C; Hugli TE
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1833-7. PubMed ID: 6940191
[TBL] [Abstract][Full Text] [Related]
17. A direct in vivo comparison of the inflammatory properties of human C5a and C5a des Arg in human skin.
Swerlick RA; Yancey KB; Lawley TJ
J Immunol; 1988 Apr; 140(7):2376-81. PubMed ID: 3351304
[TBL] [Abstract][Full Text] [Related]
18. Chemotactic factor inactivator interaction with Gc-globulin (vitamin D-binding protein). A mechanism of modulating the chemotactic activity of C5a.
Robbins RA; Hamel FG
J Immunol; 1990 Mar; 144(6):2371-6. PubMed ID: 2313096
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the interaction of human C5a and C5a des Arg with human monocytes and neutrophils: flow cytometric and chemotaxis studies.
Yancey KB; Lawley TJ; Dersookian M; Harvath L
J Invest Dermatol; 1989 Feb; 92(2):184-9. PubMed ID: 2493055
[TBL] [Abstract][Full Text] [Related]
20. Identification of neutrophil chemotactic factors in bronchoalveolar lavage fluid of asthmatic patients.
Teran LM; Campos MG; Begishvilli BT; Schröder JM; Djukanovic R; Shute JK; Church MK; Holgate ST; Davies DE
Clin Exp Allergy; 1997 Apr; 27(4):396-405. PubMed ID: 9146932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
